M. Gordon

M. Gordon, Jennifer S. Harthan, Christina E. Morettin, 2021, Optometry and vision science : official publication of the American Academy of Optometry.

The development of a decision analytic model of changes in mean deviation in people with glaucoma: the COA model.

Chris A. Johnson, Dustin L. Stwalley, M. Gordon, 2012, Ophthalmology.

Effect of patient's life expectancy on the cost-effectiveness of treatment for ocular hypertension.

Michael V. Boland, M. Kass, M. Gordon, 2010, Archives of ophthalmology.

Rate of falls, fear of falling, and avoidance of activities at-risk for falls in older adults with glaucoma.

Monica S. Perlmutter, M. Gordon, A. Bhorade, 2021, American journal of ophthalmology.

The Ocular Hypertension Treatment Study: design and baseline description of the participants.

M. Kass, M. Gordon, M A Kass, 1999, Archives of ophthalmology.

Assessment of Cumulative Incidence and Severity of Primary Open-Angle Glaucoma Among Participants in the Ocular Hypertension Treatment Study After 20 Years of Follow-up.

Chris A. Johnson, J. Miller, M. Kass, 2021, JAMA ophthalmology.

Densitometric profiles of optic disc hemorrhages in the Ocular Hypertension Treatment Study.

Lucy Q. Shen, L. Pasquale, R. Ritch, 2020, American journal of ophthalmology.

Accuracy of Kalman Filtering in Forecasting Visual Field and Intraocular Pressure Trajectory in Patients With Ocular Hypertension.

Gian-Gabriel P. Garcia, Mariel S. Lavieri, Xiang Liu, 2019, JAMA ophthalmology.

What We Have Learned From the Ocular Hypertension Treatment Study.

M. Kass, M. Gordon, 2018, American journal of ophthalmology.

Thirteen-Year Follow-up of Optic Disc Hemorrhages in the Ocular Hypertension Treatment Study.

M. Kass, M. Gordon, S. Gedde, 2017, American journal of ophthalmology.

Rate of visual field progression in eyes with optic disc hemorrhages in the ocular hypertension treatment study.

R. Ritch, M. Kass, M. Gordon, 2012, Archives of ophthalmology.

Rate of Visual Field Progression in Eyes With Optic Disc Hemorrhages in the Ocular Hypertension Treatment Study

R. Ritch, M. Kass, M. Gordon, 2012 .

Effect of treatment on the rate of visual field change in the ocular hypertension treatment study observation group.

R. Ritch, M. Kass, M. Gordon, 2012, Investigative ophthalmology & visual science.

The incidence of retinal vein occlusion in the ocular hypertension treatment study.

M. Kass, M. Gordon, B. Wilson, 2010, Ophthalmology.

Comparison of initial intraocular pressure response with topical beta-adrenergic antagonists and prostaglandin analogues in African American and white individuals in the Ocular Hypertension Treatment Study.

J. Beiser, M. Kass, M. Gordon, 2007, Archives of ophthalmology.

Baseline risk factors for the development of primary open-angle glaucoma in the Ocular Hypertension Treatment Study.

J. Beiser, M. Kass, M. Gordon, 2004, American journal of ophthalmology.

Safety and tolerability of a one-time, in-office administration of 5% povidone-iodine in the treatment of adenoviral conjunctivitis: The Reducing Adenoviral Patient Infected Days (RAPID) study.

M. Gordon, Jennifer S. Harthan, Christina E. Morettin, 2019, The ocular surface.

Reproducibility of Detecting Silent Cerebral Infarcts in Pediatric Sickle Cell Anemia

Bruce A. Vendt, M. Gordon, M. Kraut, 2014, Journal of child neurology.

Lens fluorescence and accommodative amplitude in pre-presbyopic and presbyopic subjects.

M. Gordon, S. Kymes, S. Bassnett, 2007, Experimental eye research.

Intraocular pressure and visual field progression in open-angle glaucoma.

M. Kass, M. Gordon, 2000, American journal of ophthalmology.

Detecting Glaucoma in the Ocular Hypertension Treatment Study Using Deep Learning: Implications for clinical trial endpoints

D. Kriegman, M. Goldbaum, M. Kass, 2021 .

Incorporating the results of the Ocular Hypertension Treatment Study into clinical practice.

M. Kass, M. Gordon, S. Kymes, 2005, Archives of ophthalmology.

Neuroimaging Features of Idiopathic Intracranial Hypertension Persist After Resolution of Papilloedema

M. Gordon, Aseem Sharma, J. Huecker, 2016, Neuro-ophthalmology.

A dose-response study of the effect of levobunolol on ocular hypertension.

M. Kass, M. Gordon, L. Partamian, 1983, American journal of ophthalmology.

Comparing statistical methods in assessing the prognostic effect of biomarker variability on time-to-event clinical outcomes

M. Gordon, F. Gao, C. Xiong, 2022, BMC Medical Research Methodology.

The 10-year incidence of glaucoma among patients with treated and untreated ocular hypertension.

F. Gao, J. Miller, J. Beiser, 2011, Archives of ophthalmology.

Erratum

Yeunjoo E. Song, J. Haines, M. Pericak-Vance, 1937, Biological Psychiatry.

Factors Associated with Adherence to Screening Guidelines for Diabetic Retinopathy Among Low-Income Metropolitan Patients.

M. Gordon, B. Wilson, R. Rajagopal, 2020, Missouri medicine.

Intraocular pressure response to topical dexamethasone as a predictor for the development of primary open-angle glaucoma.

M. Kass, M. Gordon, B. Becker, 1988, American journal of ophthalmology.

WITHDRAWN: Neuroimaging Features of Idiopathic Intracranial Hypertension Persist After Resolution of Papilledema

M. Gordon, Aseem Sharma, J. Huecker, 2016 .

Diagnostic accuracy of clinical signs, symptoms and point-of-care testing for early adenoviral conjunctivitis

M. Gordon, Jennifer S. Harthan, Christina E. Morettin, 2021, Clinical & experimental optometry.

Predictive Accuracy and Densitometric Analysis of Point-of-Care Immunoassay for Adenoviral Conjunctivitis

M. Gordon, Jennifer S. Harthan, Christina E. Morettin, 2021, Translational vision science & technology.

Retinocortical conduction time in diabetics with abnormal pattern reversal electroretinograms and visual evoked potentials

R. Burde, M. Gordon, G. Trick, 1988, Documenta Ophthalmologica.

Clinical Application of the 20-Year Results from the Ocular Hypertension Treatment Study (OHTS)-Reply.

M. Kass, M. Gordon, 2021, JAMA ophthalmology.

The Characterization and Comparison of OHTS Abnormal Visual Field Classifications using the 24-2 vs. the 30-2 Testing Strategies

Chris A. Johnson, John L. Keltner, Kimberly E. Cello, 2002 .

CONFIRMATION OF VISUAL FIELD ABNORMALITIES IN THE OCULAR HYPERTENSION TREATMENT STUDY (OHTS)

Chris A. Johnson, John L. Keltner, Michael A. Kass, 1999 .

Estimating correlation between multivariate longitudinal data in the presence of heterogeneity

F. Gao, J. Beiser, M. Gordon, 2017, BMC Medical Research Methodology.

Differences in keratoconus as a function of gender.

M. Gordon, K. Zadnik, T. Mcmahon, 2005, American journal of ophthalmology.

Compliance with topical pilocarpine treatment.

M. Kass, M. Gordon, J. Goldberg, 1986, American journal of ophthalmology.

Acetazolamide and urolithiasis.

M. Kass, M. Gordon, I. Goldberg, 1981, Ophthalmology.

Classification of visual field abnormalities in the ocular hypertension treatment study.

Chris A Johnson, Chris A. Johnson, Mae O Gordon, 2000, Archives of ophthalmology.

Corneal Scarring and Vision in Keratoconus: A Baseline Report from the Collaborative Longitudinal Evaluation of Keratoconus (CLEK) Study

M. Gordon, K. Zadnik, T. Edrington, 2000, Cornea.

Changes in the quality-of-life of people with keratoconus.

Karla Zadnik, Mae O Gordon, M. Gordon, 2008, American journal of ophthalmology.

Biomicroscopic Signs and Disease Severity in Keratoconus

Joseph T. Barr, Karla Zadnik, Timothy B. Edrington, 1996 .

Quality of life in keratoconus.

M. Gordon, K. Zadnik, S. Kymes, 2004, American journal of ophthalmology.

Biomicroscopic signs and disease severity in keratoconus. Collaborative Longitudinal Evaluation of Keratoconus (CLEK) Study Group.

M. Gordon, K. Zadnik, T. Edrington, 1996, Cornea.

Rigid contact lens fitting relationships in keratoconus. Collaborative Longitudinal Evaluation of Keratoconus (CLEK) Study Group.

M. Gordon, K. Zadnik, T. Edrington, 1999, Optometry and vision science : official publication of the American Academy of Optometry.

Rigid contact lens fitting relationships in keratoconus

M. Gordon, K. Zadnik, T. Edrington, 1999 .

Changes in central corneal thickness over time: the ocular hypertension treatment study.

Mae O Gordon, Julia A Beiser, J. Beiser, 2008, Ophthalmology.

Corneal scarring in the Collaborative Longitudinal Evaluation of Keratoconus (CLEK) Study: baseline prevalence and repeatability of detection.

M. Gordon, K. Zadnik, K. Schechtman, 1999, Cornea.

Estimation of the incidence and factors predictive of corneal scarring in the Collaborative Longitudinal Evaluation of Keratoconus (CLEK) Study.

M. Gordon, K. Zadnik, M. Rah, 2006, Cornea.

Estimation of the Incidence and Factors Predictive of Corneal Scarring in the Collaborative Longitudinal Evaluation of Keratoconus (CLEK) Study

M. Gordon, K. Zadnik, M. Rah, 2006 .

Feasibility of Fitting Contact Lenses with Apical Clearance in Keratoconus

M. Gordon, K. Zadnik, T. Mcmahon, 1996, Optometry and vision science : official publication of the American Academy of Optometry.

Standardized Rigid Contact Lens Fitting Protocol for Keratoconus

T T McMahon, M. Gordon, K. Zadnik, 1996, Optometry and vision science : official publication of the American Academy of Optometry.

Factors Associated with Corneal Scarring in the Collaborative Longitudinal Evaluation of Keratoconus (CLEK) Study

M. Gordon, K. Zadnik, T. Edrington, 2000, Cornea.

Repeatability and Agreement of Two Corneal‐Curvature Assessments in Keratoconus: Keratometry and the First Definite Apical Clearance Lens (FDACL)

M. Gordon, K. Zadnik, T. Edrington, 1998, Cornea.

Central corneal thickness in the Ocular Hypertension Treatment Study (OHTS).

J. Beiser, M. Kass, M. Gordon, 2001, Ophthalmology.

Importance of vitreous liquefaction in age-related cataract.

M. Gordon, G. Harocopos, Y. Shui, 2004, Investigative ophthalmology & visual science.

Anophthalmic Ptosis and the Effects of Enucleation on Upper Eyelid Function

M. Gordon, P. Custer, J. Huecker, 2020, Ophthalmic plastic and reconstructive surgery.

Volumetric Versus Empirical Determination of Enucleation Implant Size

M. Gordon, P. Custer, J. Huecker, 2020, Ophthalmic plastic and reconstructive surgery.

Can ophthalmologists correctly identify patients defaulting from pilocarpine therapy?

M. Kass, M. Gordon, D. Meltzer, 1986, American journal of ophthalmology.

Central corneal thickness and measured IOP response to topical ocular hypotensive medication in the Ocular Hypertension Treatment Study.

Mae O Gordon, Julia A Beiser, J. Beiser, 2004, American journal of ophthalmology.

Patient administration of eyedrops: observation. Part II.

M. Kass, M. Gordon, I. Goldberg, 1982, Annals of ophthalmology.

Visual Acuity Repeatability in Keratoconus: Impact on Sample Size

M. Gordon, K. Zadnik, K. Schechtman, 1998, Optometry and vision science : official publication of the American Academy of Optometry.

Reducing Adenoviral Patient Infected Days (RAPID) Planning Study: Agreement between Clinician and AdenoPlusTM in the Diagnosis of Adenoviral Conjunctivitis

M. Gordon, Jennifer S. Harthan, Christina E. Morettin, 2016 .

What We Have Learned From the Ocular Hypertension Treatment Study.

M. Kass, M. Gordon, 2018, American journal of ophthalmology.

Part I. Patient administration of eyedrops: interview.

M. Kass, M. Gordon, I. Goldberg, 1982, Annals of ophthalmology.

Crowdsourced Assessment of Surgical Skill Proficiency in Cataract Surgery

M. Gordon, E. Waxman, Grace L. Paley, 2021, Journal of surgical education.

The utility of the monocular trial: data from the ocular hypertension treatment study.

M. Kass, M. Gordon, R. Chang, 2010, Ophthalmology.

Cataract surgery lowers intraocular pressure and medication use in the Medication Group of the Ocular Hypertension Treatment Study.

M. Gordon, S. Mansberger, S. Gardiner, 2021, American journal of ophthalmology.

Photodocumentation of corneal scarring. Collaborative Longitudinal Evaluation of Keratoconus Study Group.

M. Gordon, K. Zadnik, T. Edrington, 1996, Journal of refractive surgery.

Frequency and severity of visual sensory and motor deficits in children with cerebral palsy: gross motor function classification scale.

L. Tychsen, M. Gordon, F. Ghasia, 2008, Investigative ophthalmology & visual science.

Validating a Pediatric Cerebral Palsy Visuomotor Impairment Questionnaire

L. Tychsen, M. Gordon, F. Ghasia, 2007 .

Repeat argon laser trabeculoplasty.

M. Kass, M. Gordon, A. Kolker, 1987, American journal of ophthalmology.

Topical timolol administration reduces the incidence of glaucomatous damage in ocular hypertensive individuals. A randomized, double-masked, long-term clinical trial.

M. Kass, M. Gordon, B. Becker, 1989, Archives of ophthalmology.

Controlled trial of transfusions for silent cerebral infarcts in sickle cell anemia.

Harold Lehmann, Michael A Kraut, Fenella J Kirkham, 2014, The New England journal of medicine.

Timolol and acetazolamide. A study of concurrent administration.

M. Kass, M. Gordon, M. Korey, 1982, Archives of ophthalmology.

Postcataract ptosis. A randomized, double-masked comparison of peribulbar and retrobulbar anesthesia.

M. Gordon, P. Custer, R. Feibel, 1993, Ophthalmology.

The rate of structural change: the confocal scanning laser ophthalmoscopy ancillary study to the ocular hypertension treatment study.

M. Kass, M. Gordon, F. Medeiros, 2013, American journal of ophthalmology.

Confirmation of visual field abnormalities in the Ocular Hypertension Treatment Study. Ocular Hypertension Treatment Study Group.

J L Keltner, M. Kass, M. Gordon, 2000, Archives of ophthalmology.

The effect of topical clonidine on intraocular pressure.

M. Kass, M. Gordon, I. Goldberg, 1981, Archives of ophthalmology.

Glaucoma Risk Alleles in the Ocular Hypertension Treatment Study.

M. Kass, M. Gordon, T. Scheetz, 2016, Ophthalmology.

Detecting Glaucoma in the Ocular Hypertension Study Using Deep Learning.

D. Kriegman, M. Goldbaum, M. Kass, 2022, JAMA ophthalmology.

Baseline topographic optic disc measurements are associated with the development of primary open-angle glaucoma: the Confocal Scanning Laser Ophthalmoscopy Ancillary Study to the Ocular Hypertension Treatment Study.

J. Beiser, M. Kass, M. Gordon, 2005, Archives of ophthalmology.

A miniature compliance monitor for eyedrop medication.

M. Kass, M. Gordon, D. Meltzer, 1984, Archives of ophthalmology.

Adjusting intraocular pressure for central corneal thickness does not improve prediction models for primary open-angle glaucoma.

J. Miller, J. Beiser, M. Kass, 2012, Ophthalmology.

The Ocular Hypertension Treatment Study Topical Medication Delays or Prevents Primary Open-angle Glaucoma in African American Individuals

J. Beiser, M. Kass, M. Gordon, 2004 .

The Ocular Hypertension Treatment Study: reproducibility of cup/disk ratio measurements over time at an optic disc reading center.

Douglas R. Anderson, M. Kass, M. Gordon, 2002, American journal of ophthalmology.

Delaying treatment of ocular hypertension: the ocular hypertension treatment study.

Chris A. Johnson, J. Miller, M. Kass, 2010, Archives of ophthalmology.

Contralateral effect of topical beta-adrenergic antagonists in initial one-eyed trials in the ocular hypertension treatment study.

J. Beiser, M. Kass, M. Gordon, 2000, American journal of ophthalmology.

Management of ocular hypertension: a cost-effectiveness approach from the Ocular Hypertension Treatment Study.

Douglas R. Anderson, J. Miller, M. Kass, 2006, American journal of ophthalmology.

The effect of a generic drug law on the retail cost of antiglaucoma medications.

M. Kass, M. Gordon, 1981, American journal of ophthalmology.

The Glaucoma Symptom Scale. A brief index of glaucoma-specific symptoms.

R. Ritch, M. Gordon, C. Mangione, 1998, Archives of ophthalmology.

Topical ocular hypotensive medication and lens opacification: evidence from the ocular hypertension treatment study.

J. Beiser, M. Kass, M. Gordon, 2006, American journal of ophthalmology.

Risk factors favoring the development of glaucomatous visual field loss in ocular hypertension.

J. Miller, M. Kass, M. Gordon, 1980, Survey of ophthalmology.

Parapapillary chorioretinal atrophy in patients with ocular hypertension. II. An evaluation of progressive changes.

M. Kass, M. Gordon, M. Wax, 1997, Archives of ophthalmology.

The accuracy and clinical application of predictive models for primary open-angle glaucoma in ocular hypertensive individuals.

J. Miller, S. Miglior, J. Beiser, 2008, Ophthalmology.

The confocal scanning laser ophthalmoscopy ancillary study to the ocular hypertension treatment study: study design and baseline factors.

Robert N Weinreb, Linda M Zangwill, Mae O Gordon, 2004, American journal of ophthalmology.

Visual Field Quality Control in the Ocular Hypertension Treatment Study (OHTS)

Chris A Johnson, Chris A. Johnson, Juanjuan Fan, 2005, Journal of glaucoma.

Neuroimaging in patients referred to a neuro-ophthalmology service: the rates of appropriateness and concordance in interpretation.

M. Gordon, J. Huecker, G. Van Stavern, 2012, Ophthalmology.

Eyebrow Position Before and After Enucleation

M. Gordon, P. Custer, J. Huecker, 2022, Ophthalmic plastic and reconstructive surgery.

Steady-state pattern electroretinogram following long term unilateral administration of timolol to ocular hypertensive subjects

M. Kass, M. Gordon, G. Trick, 1990, Documenta Ophthalmologica.

The impact of anchor point on utilities for 5 common ophthalmic diseases.

M. Gordon, S. Kymes, R. Nease, 2008, Ophthalmology.

Predicting Clinical Binary Outcome Using Multivariate Longitudinal Data: Application to Patients with Newly Diagnosed Primary Open-Angle Glaucoma.

Chengjie Xiong, J Philip Miller, Mae O Gordon, 2015, Journal of biometrics & biostatistics.

Predicting the onset of glaucoma: the confocal scanning laser ophthalmoscopy ancillary study to theOcular Hypertension Treatment Study.

M. Kass, M. Gordon, L. Zangwill, 2010, Ophthalmology.

Test-retest reproducibility of optic disk deterioration detected from stereophotographs by masked graders.

Douglas R. Anderson, M. Kass, M. Gordon, 2005, American journal of ophthalmology.

Physician-Industry Interactions and Anti-Vascular Endothelial Growth Factor Use Among US Ophthalmologists.

M. Gordon, R. Apte, J. Huecker, 2016, JAMA ophthalmology.

Effect of measurement order between right and left eyes on intraocular pressure measurement.

M. Gordon, A. Bhorade, M. Pekmezci, 2011, Archives of ophthalmology.

Baseline visual field characteristics in the ocular hypertension treatment study.

Chris A Johnson, Chris A. Johnson, Elliot Werner, 2002, Ophthalmology.

Corneal Scarring and Vision in Keratoconus

M. Gordon, K. Zadnik, T. Edrington, 2000 .

Pupillary light reaction in preclinical Alzheimer’s disease subjects compared with normal ageing controls

M. Gordon, J. Huecker, G. Van Stavern, 2018, British Journal of Ophthalmology.

A Validated Prediction Model for the Development of Primary Open Angle Glaucoma in Individuals with Ocular Hypertension The Ocular Hypertension Treatment Study Group and the European Glaucoma Prevention Study Group

S. Miglior, J. Beiser, V. Torri, 2008 .

Assessing the impact of biomedical research

Kristi L. Holmes, Cathy C. Sarli, Mae O Gordon, 2011 .

Association of Retinopathy and Insulin Resistance: NHANES 2005-2008

M. Gordon, C. Semenkovich, Yan Yan, 2020, Current eye research.

Parapapillary chorioretinal atrophy in patients with ocular hypertension. I. An evaluation as a predictive factor for the development of glaucomatous damage.

M. Kass, M. Gordon, M. Wax, 1997, Archives of ophthalmology.

The rate of visual field change in the ocular hypertension treatment study.

Robert Ritch, Stuart K Gardiner, Shaban Demirel, 2012, Investigative ophthalmology & visual science.

Risk Calculation in the Medication Arm of the Ocular Hypertension Treatment Study.

M. Gordon, J. Liebmann, G. Cioffi, 2023, Ophthalmology. Glaucoma.

The dyschromatopsia of optic neuritis is determined in part by the foveal/perifoveal distribution of visual field damage.

M. Gordon, C. Kilo, W. Hart, 1990, Investigative ophthalmology & visual science.

Series length used during trend analysis affects sensitivity to changes in progression rate in the ocular hypertension treatment study.

R. Ritch, M. Kass, M. Gordon, 2013, Investigative ophthalmology & visual science.

Calibration of the Dicon Auto Perimeter 2000 compared with that of the Goldmann perimeter.

M. Gordon, W. Hart, 1983, American journal of ophthalmology-glaucoma.

Longitudinal and cross-sectional analyses of visual field progression in participants of the Ocular Hypertension Treatment Study.

Chris A. Johnson, Douglas R. Anderson, M. Kass, 2010, Archives of ophthalmology.

The association between glaucomatous visual fields and optic nerve head features in the Ocular Hypertension Treatment Study.

Chris A. Johnson, Douglas R. Anderson, M. Kass, 2006, Ophthalmology.

Normal visual field test results following glaucomatous visual field end points in the Ocular Hypertension Treatment Study.

Chris A. Johnson, M. Kass, M. Gordon, 2005, Archives of ophthalmology.

The effect of changes in intraocular pressure on the risk of primary open-angle glaucoma in patients with ocular hypertension: an application of latent class analysis

J. Miller, S. Miglior, J. Beiser, 2012, BMC Medical Research Methodology.

Glaucomatous visual field damage. Luminance and color-contrast sensitivities.

M. Gordon, G. Trick, R. Nesher, 1990, Investigative ophthalmology & visual science.

Correlation Between Papilledema Grade and Diffusion-Weighted Magnetic Resonance Imaging in Idiopathic Intracranial Hypertension

M. Gordon, Aseem Sharma, J. Huecker, 2014, Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society.

Application of a hemolysis assay for analysis of complement activation by perfluorocarbon nanoparticles.

Nathan A. Baker, Nathan A Baker, Gregory M Lanza, 2014, Nanomedicine : nanotechnology, biology, and medicine.

A joint-modeling approach to assess the impact of biomarker variability on the risk of developing clinical outcome

Feng Gao, J. Philip Miller, Chengjie Xiong, 2011, Stat. Methods Appl..

Is a history of diabetes mellitus protective against developing primary open-angle glaucoma?

J. Beiser, M. Kass, M. Gordon, 2008, Archives of ophthalmology.

Evaluation of a Primary Open-Angle Glaucoma Prediction Model Using Long-term Intraocular Pressure Variability Data: A Secondary Analysis of 2 Randomized Clinical Trials.

J. Miller, V. Torri, M. Kass, 2020, JAMA ophthalmology.

Visual Field Loss in Patients With Diabetes in the Absence of Clinically-Detectable Vascular Retinopathy in a Nationally Representative Survey

J. McGill, M. Kass, M. Gordon, 2019, Investigative ophthalmology & visual science.

Capturing heterogeneity in repeated measures data by fusion penalty

M. Kass, J. Miller, M. Gordon, 2021, Statistics in medicine.

Baseline Topographic Optic Disc Measurements Are Associated With the Development of Primary Open Angle Glaucoma: The Confocal Scanning Laser Ophthalmoscopy Ancillary Study to the OHTS

J. Beiser, M. Kass, M. Gordon, 2005 .

Central Corneal Thickness in the Ocular Hypertension Treatment Study (OHTS).

J. Beiser, M. Kass, M. Gordon, 2020, Ophthalmology.

Frequency and severity of visual sensory and motor deficits in children with cerebral palsy: gross motor function classification scale.

L. Tychsen, M. Gordon, F. Ghasia, 2008, Investigative ophthalmology & visual science.

Title Influence of glaucomatous visual field loss on health-related quality of life Permalink

Chris A. Johnson, R. Ritch, M. Gordon, 2017 .

Magnetic Resonance Imaging of Optic Neuritis in Patients With Neuromyelitis Optica Versus Multiple Sclerosis

M. Gordon, R. Naismith, S. Khanna, 2012, Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society.

The effect of poor compliance and treatment side effects on sample size requirements in randomized clinical trials.

M. Gordon, K. Schechtman, 1994, Journal of biopharmaceutical statistics.

Steady-state pattern electroretinogram following long term unilateral administration of timolol to ocular hypertensive subjects

M. Kass, M. Gordon, G. Trick, 1990, Documenta Ophthalmologica.

Design and Baseline Description of the Participants

M. Kass, M. Gordon, 1999 .

A Longitudinal Study of the Quality of Life of People With Keratoconus: A Report From the Collaborative Longitudinal Evaluation of Keratoconus (CLEK) Study

M. Gordon, K. Zadnik, S. Kymes, 2005 .

The rate of structural change: the confocal scanning laser ophthalmoscopy ancillary study to the ocular hypertension treatment study.

M. Kass, M. Gordon, F. Medeiros, 2013, American journal of ophthalmology.

What is the Optimal Frequency of Visual Field Testing to Detect Rapid Progression Among Hypertensive Eyes?

M. Kass, M. Gordon, J. Liebmann, 2023, Journal of glaucoma.

Differences in vision between clinic and home and the effect of lighting in older adults with and without glaucoma.

Monica S. Perlmutter, M. Gordon, A. Bhorade, 2013, JAMA ophthalmology.

Rates of Visual Field Change in Eyes with Optic Disc Hemorrhage in the Ocular Hypertension Treatment Study

R. Ritch, M. Kass, M. Gordon, 2011 .

A14 Recruitment for a large-scale clinical study via the internet

M. Gordon, M. Bullimore, K. Zadnik, 1996 .

The development of a decision analytic model of changes in mean deviation in people with glaucoma: the COA model.

Chris A. Johnson, Dustin L. Stwalley, M. Gordon, 2012, Ophthalmology.

Correlation of Adenoviral Titers with Severity of Adenoviral Conjunctivitis and Time to Viral Clearance for 21 Days

M. Gordon, Jennifer S. Harthan, Christina E. Morettin, 2023, Optometry and vision science : official publication of the American Academy of Optometry.